1

2
Noriko Oku legal representative, Chikako Oku legal representative, Tomohito Oku legal representative, Hiroshi Kayakiri, Yoshito Abe, Hitoshi Hamashima, Hitoshi Sawada, Naoki Ishibashi, Hiroyuki Setoi, Noritsugu Yamasaki, Takafumi Imoto, Takahiro Hiramura: Imidazole compounds and medicinal use thereof. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, June 13, 2006: US07060721 (39 worldwide citation)

Imidazole compounds represented by general formula (I): wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseas ...


3

4

5
Hiroyuki Setoi, Takehiko Ohkawa, Tatsuya Zenkoh, Hitoshi Sawada, Kentaro Sato, Hirokazu Tanaka: Benzamide derivatives and their use as vasopressin antagonists. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, April 25, 2000: US06054457 (25 worldwide citation)

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc, and represented by general formula (I): ##STR1## wherein R.sup.1 is aryl optionally substituted with lower alkoxy, etc., R.sup.2 is lower alkyl, etc.,


6

7
Takayuki Inoue, Takashi Tojo, Masataka Morita, Yutaka Nakajima, Keiko Hatanaka, Shohei Shirakami, Hiroshi Sasaki, Akira Tanaka, Fumie Takahashi, Koichiro Mukoyoshi, Yasuyuki Higashi, Akira Okimoto, Takeshi Hondo, Hitoshi Sawada: Heterocyclic Janus Kinase 3 inhibitors. Astellas Pharma, Oblon Spivak McClelland Maier & Neustadt L, April 24, 2012: US08163767 (5 worldwide citation)

The invention relates to compound of the formula (I) or its salt, wherein —R1, —R2, —R3, —R4, —R5, -M-, —X— and —Y═ are as defined in the description, their use of as, medicament, the process for their preparation and use for the treatment of JAK3 mediated diseases.


8
Hiroshi Kayakiri, Yoshito Abe, Hitoshi Hamashima, Hitoshi Sawada, Tsuyoshi Mizutani, Teruo Oku, Noritsugu Yamasaki, Osamu Onomura, Masahiro Nishikawa, Takahiro Hiramura, Takafumi Imoto: Sulfonamide compounds and pharmaceutical use thereof. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, June 28, 2005: US06911469 (5 worldwide citation)

A sulfonamide compound of the formula (I): R1—SO2NHCO—A—X—R2  (I) wherein R1 is alky, alkenyl, alkynyl and the like; A is an optionally substitutedheteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyland 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and t ...


9

10
Kiyomitsu Kunugiza, Tadaaki Yamamoto, Hitoshi Sawada: Method of regenerating zeolite to remove acetone and water. Takeda Chemical, Wegner & Bretschneider, January 5, 1988: US04717697 (3 worldwide citation)

A method of regenerating hydrous zeolite which contains acetone as well as water after having been used to dehydrate hydrous acetone of the invention which comprises: placing the hydrous zeolite in a closed system in which a heated inert gas is circulated at a pressure more than atmospheric pressure ...